Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jan Cm Zijlmans"'
Publikováno v:
Clinical Interventions in Aging, Vol Volume 5, Pp 229-238 (2010)
Werner Poewe1, Angelo Antonini2, Jan CM Zijlmans3, Pierre R Burkhard4, François Vingerhoets51Department of Neurology, Medical University of Innsbruck, Austria; 2Parkinson Department, IRCCS San Camillo, Venice, and University of Padua, Italy; 3Depart
Externí odkaz:
https://doaj.org/article/e01cf434dee341bbbcb3f66eb12a8f0b
Publikováno v:
Clinical Interventions in Aging
Clinical Interventions in Aging, Vol. 5 (2010) pp. 229-38
Clinical Interventions in Aging, Vol. 5 (2010) pp. 229-38
After more than 40 years of clinical use, levodopa (LD) remains the gold standard of symptomatic efficacy in the drug treatment of Parkinson's disease (PD). Compared with other available dopaminergic therapies, dopamine replacement with LD is associa